Sharon Shacham
Listed on 2 Form D filings across 2+ issuers
· Director, Executive Officer
Associated issuers
- Nasus Pharma Ltd CIK 2029039 · L3
- Regenimo Biosciences, Inc. CIK 2096367 · TX
Filings (2)
-
Nasus Pharma LtdD · Feb 25, 2026 · L3 · Biotechnology$15MView filing →
-
Regenimo Biosciences, Inc.D · Nov 25, 2025 · TX · Biotechnology$2MView filing →